The present invention relates to a pharmaceutical composition including, as an active ingredient, Gypenoside LXXV or a pharmaceutically acceptable salt thereof for preventing or treating cervical cancer, a method for preventing or treating cervical cancer comprising a step of administering the pharmaceutical composition to a non-human subject, a health functional food including, as an active ingredient, Gypenoside LXXV for preventing or alleviating cervical cancer, and a feed composition including, as an active ingredient, Gypenoside LXXV for preventing or alleviating cervical cancer.